ArticleCureus2026
Evaluation of Changes in Central Macular Thickness After Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) Posterior Capsulotomy: An Optical Coherence Tomography-Based Prospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background After cataract surgery, one of the most common complications causing diminution of vision is posterior capsular opacification (PCO). Neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy is currently the most popular option for treating PCO, as it is a fast, non-invasive, and successful procedure. Methodology This prospective observational study was conducted at a tertiary eye care center in central India. A total of 64 pseudophakic patients were included. Preoperative evaluation included a detailed demographic history and complete ophthalmological examination, including visual acuity, intraocular pressure (IOP), and central macular thickness (CMT). All patients underwent Nd:YAG laser capsulotomy for PCO. Following laser treatment, IOP, best-corrected visual acuity (BCVA), and CMT were evaluated after three and eight weeks. Optical coherence tomography (OCT) was used to measure CMT. The data analysis was done using suitable statistical tests. Results A total of 64 patients who met the inclusion criteria were enrolled. There was a significant and stable improvement in BCVA, with mean BCVA improving from baseline 0.82 ± 0.15 logMAR preoperatively to 0.12 ± 0.09 logMAR postoperatively (p < 0.001). Regarding CMT values, post-laser macular thickness at three weeks (mean ± SD = 241.50 ± 10.76) was significantly increased (p < 0.001) compared to pre-laser macular thickness (mean ± SD = 222.89 ± 9.23); however, it was statistically non-significant at eight weeks (p = 0.08). Most patients remained within the 10-16 mmHg IOP range throughout the follow-up period. Conclusions Nd:YAG laser posterior capsulotomy is a quick, safe, and non-invasive procedure for PCO. Increased macular thickness was reported as a complication after performing YAG laser posterior capsulotomy, lasting for a substantial period, which was revealed on follow-up with OCT. As this was not clinically observed, it did not necessitate regular prophylactic treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.